Glucose Metabolism in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers, with a five-year survival rate of around 5% to 8%. To date, very few available drugs have been successfully used to treat PDAC due to the poor understanding of the tumor-specific features. One of the hallmarks...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Liang, Raj, Priyank, Yao, Wantong, Ying, Haoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826406/
https://www.ncbi.nlm.nih.gov/pubmed/31569510
http://dx.doi.org/10.3390/cancers11101460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826406/
https://www.ncbi.nlm.nih.gov/pubmed/31569510
http://dx.doi.org/10.3390/cancers11101460

Ejemplares similares